Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of cli...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Scruggs, Brittni A., Semon, Julie A., Zhang, Xiujuan, Zhang, Shijia, Bowles, Annie C., Pandey, Amitabh C., Imhof, Kathleen M.P., Kalueff, Allan V., Gimble, Jeffrey M., Bunnell, Bruce A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2013
Soggetti:
Tissue Engineering and Regenerative Medicine
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785264/
https://ncbi.nlm.nih.gov/pubmed/24018793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0026
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi